{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:19:24Z","timestamp":1787509164169,"version":"build-2736575974"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.saa.2023.122911","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T11:59:29Z","timestamp":1684929569000},"page":"122911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Sustainable Stability-Indicating spectra manipulations for the concurrent quantification of a novel Anti-COVID-19 drug and its active Metabolite: Green profile assessment"],"prefix":"10.1016","volume":"300","author":[{"given":"Michael","family":"Gamal Fawzy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0293-9890","authenticated-orcid":false,"given":"Ebraam B.","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2023.122911_b0005","unstructured":"2021 (https:\/\/covid19.who.int. opens in new tab) WHO coronavirus (COVID-19) dashboard. Geneva: World Health Organization, No Title."},{"key":"10.1016\/j.saa.2023.122911_b0010","doi-asserted-by":"crossref","unstructured":"C.E. Wagner, C.M. Saad-Roy, S.E. Morris, R.E. Baker, M.J. Mina, J. Farrar, E.C. Holmes, O.G. Pybus, A.L. Graham, E.J. Emanuel, Vaccine nationalism and the dynamics and control of SARS-CoV-2, Science (80-.). 373 (2021) eabj7364.","DOI":"10.1126\/science.abj7364"},{"issue":"2021","key":"10.1016\/j.saa.2023.122911_b0015","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1080\/07853890.2021.1957998","article-title":"Changes in COVID-19 vaccination receipt and intention to vaccinate by socioeconomic characteristics and geographic area, United States, January 6\u2013March 29","volume":"53","author":"Nguyen","year":"2021","journal-title":"Ann. Med."},{"key":"10.1016\/j.saa.2023.122911_b0020","doi-asserted-by":"crossref","unstructured":"J.R. Arribas, S. Bhagani, S.M. Lobo, I. Khaertynova, L. Mateu, R. Fishchuk, W.Y. Park, K. Hussein, S.W. Kim, J. Ghosn, M.L. Brown, Y. Zhang, W. Gao, C. Assaid, J.A. Grobler, J. Strizki, M. Vesnesky, A. Paschke, J.R. Butterton, C. De Anda, Randomized Trial of Molnupiravir or Placebo in Patients Hospitalized with Covid-19, NEJM Evid. 1 (2022) EVIDoa2100044. https:\/\/doi.org\/10.1056\/EVIDoa2100044.","DOI":"10.1056\/EVIDoa2100044"},{"key":"10.1016\/j.saa.2023.122911_b0025","first-page":"628","article-title":"Neutralizing antibody therapeutics for COVID-19","volume":"13","author":"Hurt","year":"2021","journal-title":"Virutilizes."},{"key":"10.1016\/j.saa.2023.122911_b0030","doi-asserted-by":"crossref","unstructured":"A. Gupta, Y. Gonzalez-Rojas, E. Juarez, M. Crespo Casal, J. Moya, D.R. Falci, E. Sarkis, J. Solis, H. Zheng, N. Scott, A.L. Cathcart, C.M. Hebner, J. Sager, E. Mogalian, C. Tipple, A. Peppercorn, E. Alexander, P.S. Pang, A. Free, C. Brinson, M. Aldinger, A.E. Shapiro, Early Treatment for Covid-19 with SARS-CoV-2 Neutralizing Antibody Sotrovimab, N. Engl. J. Med. 385 (2021) 1941\u20131950. https:\/\/doi.org\/10.1056\/NEJMoa2107934.","DOI":"10.1056\/NEJMoa2107934"},{"key":"10.1016\/j.saa.2023.122911_b0035","article-title":"Molnupiravir, an Oral Antiviral Treatment for COVID-19., MedRxiv Prepr","author":"Fischer","year":"2021","journal-title":"Serv. Heal. Sci."},{"issue":"2021","key":"10.1016\/j.saa.2023.122911_b0040","first-page":"1717","article-title":"Outpatient Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 Infection to Prevent Coronavirus Disease 2019 Progression","volume":"73","author":"Cohen","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.saa.2023.122911_b0045","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/s41564-020-00835-2","article-title":"Therapeutically administered ribonucleoside analogue MK-4482\/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets","volume":"6","author":"Cox","year":"2021","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.saa.2023.122911_b0050","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/s41586-021-03312-w","article-title":"SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801","volume":"591","author":"Wahl","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.saa.2023.122911_b0055","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/infdis\/jiab361","article-title":"Molnupiravir inhibits replication of the emerging SARS-CoV-2 variants of concern in a hamster infection model","volume":"224","author":"Abdelnabi","year":"2021","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.saa.2023.122911_b0060","doi-asserted-by":"crossref","first-page":"e01348","DOI":"10.1128\/JVI.01348-19","article-title":"Small-Molecule Antiviral \u03b2- d - N 4 -Hydroxycytidine Inhibits a Proofreading-Intact Coronavirus with a High Genetic Barrier to Resistance","volume":"93","author":"Agostini","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.saa.2023.122911_b0065","doi-asserted-by":"crossref","first-page":"e01965","DOI":"10.1128\/JVI.01965-17","article-title":"\u03b2-d-N 4-hydroxycytidine is a potent anti-alphavirus compound that induces a high level of mutations in the viral genome","volume":"92","author":"Urakova","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.saa.2023.122911_b0070","doi-asserted-by":"crossref","unstructured":"J. Grobler, J. Strizki, N. Murgolo, W. Gao, Y. Cao, Y. Zhang, J. Du, M. Nair, Y. Huang, Y. Luo, 543. Molnupiravir Maintains Antiviral Activity Against SARS-CoV-2 Variants In Vitro and in Early Clinical Studies, in: Open Forum Infect. Dis., Oxford University Press US, 2021: pp. S373\u2013S373.","DOI":"10.1093\/ofid\/ofab466.742"},{"key":"10.1016\/j.saa.2023.122911_b0075","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1038\/s41594-021-00651-0","article-title":"Mechanism of molnupiravir-induced SARS-CoV-2 mutagenesis","volume":"28","author":"Kabinger","year":"2021","journal-title":"Nat. Struct. Mol. Biol."},{"key":"10.1016\/j.saa.2023.122911_b0080","unstructured":"ICH Q1A(R2), International Conference on Harmonization (ICH). Guidance for industry: Q1A(R2) Stability testing of new drug substances and products, Ich Harmon. Tripart. Guidel. 4 (2003) 24."},{"key":"10.1016\/j.saa.2023.122911_b0085","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13065-023-00927-0","article-title":"HPLC-DAD technique for the quantification of a recently approved anti-diabetic triple combination along with two toxic official impurities: Toxicity confirmation aided by molecular docking application","volume":"17","author":"Bahgat","year":"2023","journal-title":"BMC Chem."},{"key":"10.1016\/j.saa.2023.122911_b0090","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1093\/jaoacint\/qsab080","article-title":"Smart Mathematical Manipulation \u03bff Spectral Signals: Stability Indicating, f\u03bfr the Estimation of S\u03bflifenacin Succinate: Anti-Muscarinic Drug, in Existence \u03bff Its Acid Degradati\u03bfn Product","volume":"105","author":"Fayed","year":"2022","journal-title":"J. AOAC Int."},{"key":"10.1016\/j.saa.2023.122911_b0095","doi-asserted-by":"crossref","unstructured":"E.B. Kamel, Two green chromatographic methods for the quantification of tamsulosin and solifenacin along with four of their impurities, J. Sep. Sci. 45 (2022) 1305\u20131316. https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/abs\/10.1002\/jssc.202100980.","DOI":"10.1002\/jssc.202100980"},{"key":"10.1016\/j.saa.2023.122911_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2023.108683","article-title":"Stability-indicating HPLC-DAD and TLC-densitometry methods for the quantification of bupivacaine and meloxicam in their co-formulated mixture","volume":"190","author":"Bahgat","year":"2023","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2023.122911_b0105","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/bio.4458","article-title":"Green micelle and complex inclusion enhance synchronous spectrofluorimetric quantification of a novel analgesic combination: Tramadol and celecoxib in tablet dosage form and spiked human plasma","volume":"38","author":"Bahgat","year":"2023","journal-title":"Luminescence"},{"key":"10.1016\/j.saa.2023.122911_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114356","article-title":"The development and validation of a novel LC-MS\/MS method for the simultaneous quantification of Molnupiravir and its metabolite \u00df-d-N4-hydroxycytidine in human plasma and saliva","volume":"206","author":"Amara","year":"2021","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2023.122911_b0115","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.9734\/jpri\/2021\/v33i60B34973","article-title":"Method Development and Validation of a Specific Stability Indicating RP-HPLC Method for Molnupiravir API","author":"Kumar","year":"2021","journal-title":"J. Pharm. Res. Int."},{"key":"10.1016\/j.saa.2023.122911_b0120","doi-asserted-by":"crossref","unstructured":"T. Re\u00e7ber, S.S. Timur, S. Erdo\u011fan Kablan, F. Yal\u00e7\u0131n, T.C. Karabulut, R. Neslihan G\u00fcrsoy, H. Ero\u011flu, S. K\u0131r, E. Nemutlu, A stability indicating RP-HPLC method for determination of the COVID-19 drug molnupiravir applied utilizing nanoformulations in permeability studies, J. Pharm. Biomed. Anal. 214 (2022) 114693. https:\/\/doi.org\/10.1016\/j.jpba.2022.114693.","DOI":"10.1016\/j.jpba.2022.114693"},{"key":"10.1016\/j.saa.2023.122911_b0125","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.3390\/molecules27072330","article-title":"Two Green Micellar HPLC and Mathematically Assisted UV Spectroscopic Methods for the Simultaneous Determination of Molnupiravir and Favipiravir as a Novel Combined COVID-19 Antiviral Regimen","volume":"27","author":"Sharaf","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.saa.2023.122911_b0130","doi-asserted-by":"crossref","DOI":"10.1002\/jssc.202200178","article-title":"Highly sensitive high-performance thin-layer chromatography method for the simultaneous determination of molnupiravir, favipiravir, and ritonavir in pure forms and pharmaceutical formulations","author":"Saraya","year":"2022","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.saa.2023.122911_b0135","doi-asserted-by":"crossref","first-page":"5939","DOI":"10.5958\/0974-360X.2020.01037.9","article-title":"Spectrophotometry analysis for simultaneous determination of the new antiviral drug combination: Daclatasvir\/sofosbuvir in their pure form and pharmaceutical preparation","volume":"13","author":"Eissa","year":"2020","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.saa.2023.122911_b0140","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1021\/ac00232a034","article-title":"Fourier Transforms in the Computation of Self-Deconvoluted and First-Order Derivative Spectra of Overlapped Band Contours","volume":"53","author":"Kaupplnen","year":"1981","journal-title":"Anal. Chem."},{"key":"10.1016\/j.saa.2023.122911_b0145","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1366\/000370209788701161","article-title":"The role and selection of the filter function in Fourier self-deconvolution revisited","volume":"63","author":"L\u00f3renz-Fonfr\u00eda","year":"2009","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.saa.2023.122911_b0150","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1366\/0003702834634271","article-title":"Some Observations on the Resolution Enhancement of Spectral Data by the Method of Self-Deconvolution","volume":"37","author":"Jones","year":"1983","journal-title":"Appl. Spectrosc."},{"key":"10.1016\/j.saa.2023.122911_b0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.saa.2015.04.076","article-title":"A comparative study of smart spectrophotometric methods for simultaneous determination of sitagliptin phosphate and metformin hydrochloride in their binary mixture","volume":"149","author":"Lotfy","year":"2015","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.122911_b0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.saa.2018.06.072","article-title":"Different resolution techniques for management of overlapped spectra: Application for the determination of novel co-formulated hypoglycemic drugs in their combined pharmaceutical dosage form","volume":"205","author":"Moussa","year":"2018","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.122911_b0165","unstructured":"International Conference on Harmonization (ICH), Q2B: validation of analytical procedures: methodology, 62, US FDA, Federal Register, (2005)."},{"key":"10.1016\/j.saa.2023.122911_b0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.microc.2020.105557","article-title":"Analytical tools for greenness assessment of chromatographic approaches: Application to pharmaceutical combinations of Indapamide, Perindopril and Amlodipine","volume":"159","author":"Saleh","year":"2020","journal-title":"Microchem. J."},{"key":"10.1016\/j.saa.2023.122911_b0175","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."},{"key":"10.1016\/j.saa.2023.122911_b0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.120998","article-title":"Different approaches for the assessment of greenness of spectrophotometric methodologies utilized for resolving the spectral overlap of newly approved binary hypoglycemic pharmaceutical mixture","volume":"272","author":"Fawzy","year":"2022","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.122911_b0185","article-title":"A green spectrophotometric method for the simultaneous determination of nasal binary mixture utilized in respiratory diseases: Applying isosbestic point and chemometric approaches as a resolving tool, greenness evaluation","author":"Gamal Fawzy","year":"2022","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2023.122911_b0190","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2023.122911_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"TrAC Trends Anal. Chem."},{"key":"10.1016\/j.saa.2023.122911_b0200","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.microc.2019.03.038","article-title":"Experimental design methodology for optimization and robustness determination in ion pair RP-HPLC method development: Application for the simultaneous determination of metformin hydrochloride, alogliptin benzoate and repaglinide in tablets","volume":"147","author":"Mahroutilize","year":"2019","journal-title":"Microchem. J."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523005966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142523005966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T02:28:17Z","timestamp":1761359297000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142523005966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":40,"alternative-id":["S1386142523005966"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2023.122911","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sustainable Stability-Indicating spectra manipulations for the concurrent quantification of a novel Anti-COVID-19 drug and its active Metabolite: Green profile assessment","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2023.122911","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"122911"}}